Aesku.Diagnostics GmbH, a leading name in the diagnostics industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 2009, the company has established itself as a pioneer in the development of innovative diagnostic solutions, particularly in the fields of autoimmune diseases and infectious diseases. Aesku.Diagnostics offers a range of unique products, including advanced immunoassays and molecular diagnostics, which are distinguished by their accuracy and reliability. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner for laboratories and healthcare providers. With a strong market presence, Aesku.Diagnostics is recognised for its contributions to improving patient outcomes through cutting-edge technology and exceptional service. The company continues to drive advancements in diagnostics, ensuring it remains at the forefront of the industry.
How does Aesku.Diagnostics GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Aesku.Diagnostics GmbH's score of 20 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aesku.Diagnostics GmbH, headquartered in Germany, currently does not have available carbon emissions data for the most recent year. As such, there are no specific figures regarding their total emissions or breakdowns by Scope 1, 2, or 3. Additionally, the company has not outlined any reduction targets or commitments to climate initiatives, nor does it appear to be part of any industry-standard climate pledges such as the Science Based Targets initiative (SBTi). Given the absence of emissions data and reduction initiatives, Aesku.Diagnostics GmbH's climate commitments remain unclear. The company may need to enhance its transparency and engagement in climate action to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aesku.Diagnostics GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.